Arvelle Therapeutics - Ownership and Business Overview

Life ScienceCompany

Arvelle Therapeutics Ownership

Who owns Arvelle Therapeutics?

Arvelle Therapeutics is owned by Angelini. It was acquired on January 5, 2021.

Was Arvelle Therapeutics formerly PE-backed?

Yes. Arvelle Therapeutics was formerly owned by 2 private investors.

Arvelle Therapeutics Business Overview

Where is Arvelle Therapeutics headquartered?

Arvelle Therapeutics is headquartered in Zug, Switzerland.

What sector is Arvelle Therapeutics in?

Arvelle Therapeutics is a life science company.

When was Arvelle Therapeutics founded?

Arvelle Therapeutics was founded in 2019.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

Arvelle Therapeutics

Arvelle Therapeutics International GmbH

Zählerweg 6,
Zug, 6301
Switzerland,
+41 44 5672940
www.arvelletx.com

Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Arvelle Therapeutics

Life Science Companies , Switzerland Companies